Bioprocess International

Location:Boston Conference and Expo Center
Date:10/04/2016 - 10/07/2016
City, State & Country:Boston, MA, USA
Pall Booth:521 (BioPharm) and 1355 (Cell Therapy)
Event Summary:

General BioPharm, and Cell Therapy

Equipment/Products on Display:  

  •     End-to-end Continuous Bioprocessing
  •     Allegro™  STR2000 Single-use Bioreactor launch
  •     Cadence™ BioSMB Process System launch
  •     Cadence™ Acoustic Separator
  •     Cadence™ in-line concentrator
  •     Pegasus™ Prime virus filter launch
  •     Kleenpak™ Presto sterile connector


A full portfolio of Cell, Gene Therapy and Vaccine enabling products

    iCELLis® 500 Process System


Talks:

TUESDAY, OCTOBER 4, 2016
 
9AM – 5PM:  Sponsor:  Continuous Processing Symposium 2
Chairperson:  Marc Bisschops, PhD. Technology Director, Continuous Bioprocessing, Pall Life Sciences, Holland
Session includes:
Presenter:  Marc Schofield, PhD, Principal R&D Engineer, Pall Life Sciences
Topic:  Process Chromatography Platform for the Operation of Continuous Bioprocessing

Presenter:  Mani Krishnan, Senior Vice President, Technical and Scientific Affairs, Pall Life Sciences
Topic:  Applying ICH Q8/Q9 to Continuous Processing
 
WEDNESDAY, OCTOBER 5, 2016
 
9:30AM:  Presenter:  Michael Egholm, VP and General Manager, Pall Pharmaceuticals
Topic:  Opening Breakfast Presentation;  Pall Biopharmaceuticals' Leader Provides an Update on Significant Technology Advances Enabling Integrated Continuous BioProcessing
 
10:30AM:  Session Sponsor and Chair: CELL CULTURE & UPSTREAM PROCESSING
Integrated Continuous Processing for Cell Culture
 
Presenter:  Engin Ayturk, Ph.D., R&D Manager, BioPharm Applications R&D, Pall Corporation
Topic:  End-to-End Integrated Continuous BioProcessing  Platform for Biologics Manufacturing
 
2:15PM:  Presenter:  Hanna Lasch, FinVector Vision Therapies
Topic:  Achieving Large-Scale GMP Production of Adenovirus in the iCELLis500 Fixed-Bed Bioreactor
 
THURSDAY, OCTOBER 6, 2016
 
Presenter:  Alvin Nienow
Topic:  Cell Culture and Upstream Processing Track; "Improving Process Understanding, Control, and Productivity at Clinical and Commercial Scale"
 
FRIDAY, OCTOBER 7, 2016
 
8:35AM:  Presenter:  Dr. Rachel Legmann, Manager of Cell Culture Process Development Lab and Application Specialist, Pall Corporation
Topic:  "Industrialization of Adenoviral Vector Production in an iCELLlis® 500 Fixed Bed Bioreactor for the Creation of Autologous Insulin Producing Liver Cells for the Treatment of Diabetes: From Bench to Clinical Scale"


Event Information:
BPI